Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411513 · ClinicalTrials.gov registry record · Phase 1
Acute Treatment of Migraine Using the CEFALY Device
A Phase 1 study, sponsored by Cefaly Technology.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT02411513 is a Phase 1 study that has completed, run by Cefaly Technology. The registered enrollment target is 30 participants.
The verdict
NCT02411513, a Phase 1 study, has completed, sponsored by Cefaly Technology.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the efficacy of e-TNS with the Cefaly® device as an acute treatment for a migraine attack. This open clinical trial will study the acute treatment of migraine using the Cefaly® device, prior to development of a sham-controlled trial.
Interventions
- DEVICE CEFALY
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02411513
The ClinicalTrials.gov registry entry for NCT02411513 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cefaly Technology, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CEFALY is the first listed.
NCT02411513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02411513 about?
NCT02411513 is a clinical study titled "Acute Treatment of Migraine Using the CEFALY Device". The purpose of this study is to investigate the efficacy of e-TNS with the Cefaly® device as an acute treatment for a migraine attack. This open clinical trial will study the acute treatment of migraine using the Cefaly® device, prior to development of a sham-controlled trial.
What is the current status of trial NCT02411513?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2015-04.
What interventions are being tested in trial NCT02411513?
The interventions under investigation include: CEFALY (DEVICE).
Who is sponsoring clinical trial NCT02411513?
This trial is sponsored by Cefaly Technology, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.